Mediclinic International Plc (MDC) 2020年年度报告「LSE」.pdf

1、ENHANCINGTHE QUALITYOF LIFE2020 ANNUAL REPORTTo find out more visit:MEDICLINICS CORE PURPOSE IS TO ENHANCE THE QUALITY OF LIFESTRATEGIC REPORTIntroduction4 Section 172 statement6 Non-financial information statement7 Report profile8 Performance summary10 At a glanceBusiness overview12 Market overview

2、14 Business model16 Investment case18 Value added statement19 Five-year summaryPerformance and outlook20 Chairs Review 28 Group Chief Executive Officers Report36 Strategy,goals and progress44 Continuum of care46 Stakeholders summary50 Clinical services overview62 Sustainable development overview78 G

3、roup Chief Financial Officers Report92 Divisional Report Hirslanden100 Divisional Report Mediclinic Southern Africa106 Divisional Report Mediclinic Middle EastRisk management114 Viability statement 116 Emergency preparedness summary119 Risk management,principal risks and uncertaintiesGOVERNANCE AND

4、REMUNERATION REPORT128 Chairs Introduction130 Board of Directors136 Group Executive Committee138 Corporate Governance Statement170 Audit and Risk Committee Report184 Clinical Performance and Sustainability Committee Report188 Nomination Committee Report194 Remuneration Committee Report221 Statement

5、of Directors ResponsibilitiesFINANCIAL STATEMENTS224 Group financial statements330 Company financial statementsADDITIONAL INFORMATION348 Shareholder information351 Company information352 Forward-looking statements353 Glossary of terms1MEDICLINIC INTERNATIONAL PLC 2020 ANNUAL REPORTExpansion across t

6、he continuum of care will widen the Groups service focus,improve accessibility and create the opportunity to form a lasting relationship with clients.Across all three divisions there are opportunities to grow in existing markets,expand into new markets and become an integrated healthcare provider.44